Fundraising Fox
Prologue Medicines
1 known investors
Find your way into Prologue Medicines
Sign up to see every warm intro you have to Prologue Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prologue Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Prologue Medicines is a biotech company exploring the viral proteome using machine learning and next-generation sequencing to identify virus-evolved proteins and design programmable protein-based medicines. Founded by Flagship Pioneering, it aims to develop therapeutics that modulate human physiology beyond what human proteins can achieve.
Founders & leadership
Investors · 1
How we know: Flagship Pioneering's portfolio page · the company's own site · a partner's Signal profile · funding news · biospace.com · Not right? Tell us
Funding
SEC filings, press & company announcements$50M disclosed across 1 round · 2024
- $50MraisedMay 2024 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Prologue Medicines do?
- Prologue Medicines is a biotech company exploring the viral proteome using machine learning and next-generation sequencing to identify virus-evolved proteins and design programmable protein-based medicines. Founded by Flagship Pioneering, it aims to develop therapeutics that modulate human physiology beyond what human proteins can achieve.
- Who are Prologue Medicines's investors?
- Prologue Medicines's investors include Flagship Pioneering.
- How much funding has Prologue Medicines raised?
- Prologue Medicines has disclosed $50M raised across 1 round.